Testing & Diagnostics Q2: Healthy Profits, Mixed Results

Testing and diagnostics stocks are surging! Find out which companies blew past expectations with innovative approaches to disease detection, and which ones stumbled despite overall industry growth. We break down the winners (Quest Diagnostics, Guardant Health) and the not-so-winners (NeoGenomics) from this earnings season, revealing how new technologies and proactive healthcare are shaping the future of this critical sector. Hosted on Acast. See acast.com/privacy for more information.